“Stratus is proud to have the opportunity to support UnitedHealthcare’s initiatives to help ensure their members have access to the right care at the right time,” said Charlie Alvarez, CEO of Stratus

DALLAS (PRWEB)
March 15, 2023

Stratus™, the nation’s leading provider of EEG solutions and services, today announced it has received a national, in-network contract with UnitedHealthcare, the nation’s largest private insurer. The contract, which became effective late in 2022, provides improved access to diagnostic electroencephalogram (EEG) testing services for UnitedHealthcare members who may be experiencing seizure or seizure-like symptoms.

This national agreement offers eligible UnitedHealthcare members access to Stratus’ nationwide, in-home video EEG services without prior authorization for the test. This means many patients needing a long-term EEG will experience shorter wait times between when their physician orders a test and when the test is performed. Prior authorization can traditionally take between 14 and 30 days, so the time reduction can be significant. Additionally, UnitedHealthcare members who live outside of a major metropolitan area will also have convenient access to testing in the comfort of their own home because of Stratus’ metropolitan, suburban, and rural service offerings.

“Stratus is proud to have the opportunity to support UnitedHealthcare’s initiatives to help ensure their members have access to the right care at the right time,” said Charlie Alvarez, CEO of Stratus. “This goal fits well with Stratus’ mission of providing high-quality and convenient long-term EEG testing services to patients. Without convenient access, many patients forgo testing completely and extend the time to get answers about their medical conditions. UnitedHealthcare granting this agreement to Stratus means physicians who order tests for their patients will get the information they need faster and help them make better and more timely decisions for their patients.”

Effective immediately, Stratus can schedule physician ordered tests as in-network for most members who are part of UnitedHealthcare’s commercial, Medicare, and Medicaid health plans. For more information about Stratus and its services, please visit the company’s website: https://stratusneuro.com/about/.

###

About Stratus

Stratus is the nation’s leading provider of EEG solutions and has served more than 98,000 patients across the U.S. The company offers technology, services, and proprietary software solutions to help neurologists diagnose their patients with epilepsy and other seizure-like disorders accurately and quickly. Stratus also provides mobile cardiac telemetry to support the diagnostic testing needs of the neurology community. Additionally, the company’s R&D division holds the world’s largest database of de-identified EEG recordings and is applying machine learning to improve the overall quality and efficiency of EEG testing. To learn more, visit http://www.stratusneuro.com.

Share article on social media or email:

Slowing Down Aging May Now Be A Pill Away

“We’ve been able to develop advanced forms of these molecules and a series of complex combinations to combat aging, using the best science we have. This is truly a game-changer.” – Dr. David Brown, Ph.D., Seragon Biosciences

IRVINE, Calif. (PRWEB)
March 15, 2023

Regardless of whether the age-old myth of explorer Ponce de Leon searching for a Fountain of Youth is true, a new nutraceutical reaching the consumer market will mark a major milestone in the expedition towards improving the process of aging.

Researchers at Irvine, California-based Seragon Biosciences have developed a proprietary set of molecules that have been found to slow aging and issues that arise with aging. When integrated with a new controlled release technology, this new nutraceutical RESTORIN can attack the aging process at the cellular level.

“There are many studies that point to these molecules having a positive impact on aging and aging-related health conditions, but, so far, no one has been able to combine them at an optimal ratio to achieve a synergistic effect,” said David Brown, Ph.D., a senior scientist at Seragon who helped develop RESTORIN. “We’ve been able to develop advanced forms of these molecules and a series of complex combinations to combat aging, using the best science we have. This is truly a game-changer.”

Scientists at Seragon integrated three areas of advanced anti-aging research to develop RESTORIN: A NAD+ complex made of proprietary forms of nicotinamide adenine dinucleotide (NAD+) precursors; A SSA complex consisting of multiple senolytic agents and a group of sirtuin-activating compounds (STACs); and a group of B vitamin compounds that provide additional support to healthy aging of the brain and the nervous system.

Based on research conducted at Harvard University, Mayo Clinic, and Scripps Research, which licensed a series of core patents to Seragon, senolytic agents used in RESTORIN, can reduce senescent cells – growth-arrested cells that build up as we age and hinder tissue repair – while not affecting healthy, regular cells. Studies in mice have shown that supplementing these senolytic agents increased their remaining lifespan by as high as 60 percent.

Senescent cell accumulation is tied to many age-related issues. As we age, our cells accumulate DNA damage resulting from environmental toxins, imprecise DNA replication, mitochondrial dysfunction, and inflammation. These factors ultimately lead to the formation of new senescent cells, which continuously sprout throughout the body and tarnish vital networks that trigger organ deterioration and systemic inflammation.

What makes senolytics unique is their ability to selectively target senescent cells, thus alleviating senescent cell burden. Rodent studies have demonstrated that senolytics can enhance muscle regeneration by limiting senescent cell burden in muscle tissue. Other studies have shown that using senolytics to reduce oxidative stress and cellular senescence in the brain can improve brain health. Through a series of collaborations with Harvard, Mayo, Scripps, and other industry partners, Seragon was able to significantly enhance the bioavailability of RESTORIN’s senolytic agents, making them suitable for oral delivery.

Another key component of RESTORIN is the NAD+ precursor complex. NAD+ is an essential coenzyme in the body. Other than water itself, NAD+ is the most abundant molecule in the human body. NAD+ is a key component in our metabolic processes and immune systems and is responsible for repairing DNA damage that all of us suffer due to common and unavoidable exposure to pollutants, radiation, and more. NAD+ is also key to the function of sirtuins – guardian proteins in the body that manage cell health and are linked to longevity. In fact, as we age, our levels of NAD+ drop. And, without NAD+, we’d all be dead.

While NAD+ isn’t a new discovery (it was discovered in 1906), scientists have long tried to figure out how to supplement it. The body cannot simply absorb more NAD+ itself, so scientists have focused on how to get the body to create more of it. That’s where NAD+ precursors come in. Studies have shown they have a distinct ability to increase NAD+ production. Seragon has made advancements to effectively deliver these precursors into the body, maximizing the potential for NAD+ repletion.

In recent years, the effective delivery of NAD+ precursors has been deemed the “holy grail” of anti-aging research. To tackle this challenge, RESTORIN’s development team created proprietary, more stable forms of NAD+ precursors. They then coupled them with Seragon’s SERC™ controlled release technology that utilizes hydrophilic and lipophilic vehicles and a pH-responsive enteric delivery system to enhance cellular NAD+ levels. Researchers at Seragon concluded that these new forms of NAD+ precursor complexes, when combined with the other molecules in RESTORIN, will effectively attack aging and issues linked to aging from several angles.

“In the field of aging, a critical issue to resolve is how to deliver NAD+ precursors in a way that best boosts cellular NAD+ to achieve healthier aging,” said Dr. Brown. “We believe that RESTORIN has achieved best-in-class performance in this regard, which is truly a breakthrough. Especially when you consider recent studies showing an increase in NAD+ can even make immunotherapies against cancer more effective, it’s very exciting to be a part of this development.”

“It’s very thrilling to see aging research advancing ways to help people age slower, better, and healthier,” he added.

RESTORIN is available to consumers exclusively through its official website, http://www.restorin.com.

Sources:

Xu, Ming, et al. “Senolytics Improve Physical Function and Increase Lifespan in Old Age.” Nature Medicine, vol. 24, no. 8, 2018, p. 1246, https://doi.org/10.1038/s41591-018-0092-9 Accessed 7 Mar. 2023.

Yousefzadeh, Matthew, et al. “Fisetin Is a Senotherapeutic that Extends Health and Lifespan.” EBioMedicine, vol. 36, 2018, pp. 18-28, https://doi.org/10.1016/j.ebiom.2018.09.015. Accessed 7 Mar. 2023.

Chaib, S., Tchkonia, T. & Kirkland, J.L. Cellular senescence and senolytics: the path to the clinic. Nat Med 28, 1556–1568 (2022). https://doi.org/10.1038/s41591-022-01923-y

Dungan, C. M., Murach, K. A., Zdunek, C. J., Tang, Z. J., VonLehmden, G. L., Brightwell, C. R., Hettinger, Z., Englund, D. A., Liu, Z., Fry, C. S., Filareto, A., Franti, M., & Peterson, C. A. (2021). Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice. Aging Cell, 00, e13528. https://doi.org/10.1111/acel.13528

Ogrodnik M, Evans SA, Fielder E, Victorelli S, Kruger P, Salmonowicz H, Weigand BM, Patel AD, Pirtskhalava T, Inman CL, Johnson KO, Dickinson SL, Rocha A, Schafer MJ, Zhu Y, Allison DB, von Zglinicki T, LeBrasseur NK, Tchkonia T, Neretti N, Passos JF, Kirkland JL, Jurk D. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell. 2021 Feb;20(2):e13296. doi: 10.1111/acel.13296. Epub 2021 Jan 20. PMID: 33470505; PMCID: PMC7884042.

Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021 Feb;22(2):119-141. doi: 10.1038/s41580-020-00313-x. Epub 2020 Dec 22. PMID: 33353981; PMCID: PMC7963035.

Grabowska W, Sikora E, Bielak-Zmijewska A. Sirtuins, a promising target in slowing down the ageing process. Biogerontology. 2017 Aug;18(4):447-476. doi: 10.1007/s10522-017-9685-9. Epub 2017 Mar 3. PMID: 28258519; PMCID: PMC5514220.

Ghosh, S., Zhou, Z. SIRTain regulators of premature senescence and accelerated aging. Protein Cell 6, 322–333 (2015). https://doi.org/10.1007/s13238-015-0149-1

National Council for Prescription Drug Programs (NCPDP)

John O’Leary will deliver a powerful message of what it takes to defy harrowing odds…His exceptional recovery message is critical for NCPDP members to consider – from a patient perspective – as we tackle the critical work of closing gaps in healthcare to drive better patient outcomes.

SCOTTSDALE, Ariz. (PRWEB)
March 15, 2023

NCPDP announced today John O’Leary, childhood severe burn survivor, speaker and a bestselling author who inspires audiences with his epic story of overcoming impossible odds with determination and resilience, and of paying forward the keys to his happiness and success, will give an important keynote address at NCPDP’s 2023 Annual Technology & Business Conference, “The Great Race to Close Gaps in Care”. The Annual Conference, which will be held May 8-10, 2023, at the Westin Kierland Resort & Spa in Scottsdale, Arizona, is expected to draw more than 700 attendees representing a broad cross-section of pharmacy and other healthcare related industry segments.

“John O’Leary will deliver a powerful message of what it takes to defy harrowing odds after a childhood accident left him with a 1% chance to live,” remarked Lee Ann Stember, President & CEO of NCPDP. “With unwavering support from his care team – including his own parents – John was able to not only survive – but thrive. His exceptional recovery message is critical for NCPDP members to consider – from a patient perspective – as we tackle the critical work of closing gaps in healthcare to drive better patient outcomes.”

John O’Leary’s inspirational story began at nine-years old, when he was playing with fire and gasoline at his family home and accidentally caused an explosion that left him with burns covering 100% of his body and scant chance of survival. Despite the overwhelming odds, John went on to conquer his barriers of physical damage and emotional scarring from the accident to lead an authentic life designed around helping others conquer their own unique barriers that may be preventing them from creating inspired lives. His emotional storytelling, unexpected humor and authenticity are unforgettable. In the wake of the global pandemic, John has expanded his talks from inspirational to transformational.

John’s award-winning Live Inspired podcast has more than 2.5 million downloads and features world-renowned guests like Brené Brown, Mitch Albom, and Shawn Achor. Plus, he is a two-time #1 National Bestselling author. His first book “ON FIRE: The 7 Choices to Ignite a Radically Inspired Life” sold over 250,000 copies and was translated into 12 languages. His second book “IN AWE: Rediscover Your Childlike Wonder to Unleash Inspiration, Meaning and Joy” was published in May 2020 to much praise for the timeliness of its central message during the global pandemic.

NCPDP’s national conference draws more than 700 attendees from across the healthcare industry, including technical, business, and executive representatives from health plans, pharmacy benefit managers, retail and independent pharmacies, specialty pharmacies, long-term care providers, healthcare consultants, technology vendors, pharmaceutical manufacturers, wholesale drug distributors, database management organizations and others.

The NCPDP Annual Conference is open to all healthcare industry stakeholders. To register for the conference visit https://ncpdp.org/ac/register.aspx.

The complimentary media registration form can be downloaded here.

For real-time updates before and during the event, follow us at http://twitter.com/ncpdp or join the discussion using NCPDP’s 2023 Annual Technology & Business Conference hashtag: #NCPDP23.

Journalists: Click here to download a photo of John O’Leary.

About NCPDP

The National Council for Prescription Drug Programs (NCPDP) is a not-for-profit American National Standards Institute (ANSI) Accredited Standards Developer (ASD) consisting of more than 1,500 members representing entities including, but not limited to, claims processors, data management and analysis vendors, federal and state government agencies, insurers, intermediaries, pharmaceutical manufacturers, pharmacies, pharmacy benefit managers, professional services organizations, software and system vendors and other parties interested in electronic standardization within the pharmacy services sector of the healthcare industry. NCPDP provides a forum wherein our diverse membership can develop business solutions, including ANSI-accredited standards and guidance for promoting information exchanges related to medications, supplies and services within the healthcare system.

NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP’s RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

Share article on social media or email:

“It is inspiring to see One Company Fund supporters continue to open their hearts and their wallets to those facing unforeseen challenges.” -Tom Grape, founder, chairman and CEO of Benchmark

WALTHAM, Mass. (PRWEB)
March 15, 2023

The Benchmark One Company Fund, a non-profit which provides grants to Benchmark Senior Living employees in times of need, reports that its associate and corporate donations increased by more than 41 percent to $667,000 in 2022.

The One Company Fund is a senior living industry first launched in 2008 to give financial assistance to those who provide Benchmark residents with excellent care and experiences.

“The fact that donations increased so dramatically – despite a turbulent economic environment – speaks to the generosity and commitment our associates and corporate sponsors have to supporting the individuals who care for and bring so much happiness to our residents,” said Tom Grape, CEO and chairman of Benchmark. “It is inspiring to see One Company Fund supporters continue to open their hearts and their wallets to those facing unforeseen challenges.”

Last year, the Fund gave $325,000 in grants to associates who couldn’t purchase the necessities of life or meet financial demands created by an emergency.

Rosie Belizaire, CNA, a widow who for nine years has cared for residents at Evans Park at Newton Corner, was one of many associates who benefited from the Fund when a fire destroyed her home.

“Everything was gone. Through the Fund, I was able to access $6,750 to get me settled into a new apartment. My children and I were so happy. If it wasn’t for the Fund’s help again, I don’t know what I would have done,” said Belizaire, who had previously accessed the Fund several years ago to help family in her native Haiti following the earthquake and hurricane.

The One Company Fund was also there for Jim Salley, the director of dining services at The Atrium at Rocky Hill for over three years. In 2001, he was diagnosed with esophageal cancer. As a chef who loves food, he was devastated. “It’s the worst thing that could’ve happened to me,” he said.

The Fund gave him $9,000 to cover out-of-pocket medical expenses.

“The One Company Fund is underestimated. In a million years, I never thought I would get cancer. People overlook it because they don’t think something will happen to them. You never know what could happen,” said Salley, who is now cancer-free.

Since the Fund launched 15 years ago, it has raised over $6 million and given $3.2 million in associate grants to those affected by natural disasters, personal tragedies and other unexpected challenges.

Click here for more information about the Benchmark One Company Fund.

# # #

About Benchmark Senior Living

Benchmark is New England’s largest senior living provider with 64 independent living, assisted living, memory care and continuing care communities and over 5,000 dedicated associates providing compassionate care and outstanding experiences throughout the Northeast. The Waltham, Mass.-based company was founded over 25 years ago by Tom Grape with the purpose of Transforming Lives Through Human Connection. Since then, Benchmark has continued to set the industry standard, having won over a hundred local, regional and national awards for its care, programs and as a top workplace. Benchmark has been named one of the Top Places to Work for 15 straight years in The Boston Globe’s annual employee-based survey and received repeated recognition in FORTUNE’s Best Workplaces for Aging Services list. For more information, visit BenchmarkSeniorLiving.com.

Share article on social media or email:

Issue 48 Volume 6

Considering the dimensional changes to the bone region, following tooth extraction, alveolar ridge preservation via [GBR] can be strategically included in the treatment plan

LAWRENCE, Kan. (PRWEB)
March 15, 2023

Journal of Oral Implantology – Tooth extractions can be necessary for proper dental care and increasing the longevity of oral health. Though tooth extractions are one of the most performed surgeries in dentistry, they can cause problems maintaining the mouth’s structure and preserving the jawbone. To ensure minimal impact from tooth extraction, dental professionals often recommend guided-bone regeneration (GBR) after extraction to help regenerate supportive bone for optimal oral health.

“Considering the dimensional changes to the bone region, following tooth extraction, alveolar ridge preservation via [GBR] can be strategically included in the treatment plan,” pens Eirini Zampara, DMD, and colleagues from a multinational study group from the United States, Brazil, and Greece. Zampara et al. recently published a retrospective review in the Journal of Oral Implantology to compare three types of bone grafts to support successful GBR, including allograft, xenograft, and alloplast. The study results ultimately show that the allograft provides the greatest GBR potential for successful healing subsequent to necessary tooth extraction procedures. Zampara et al conclude that “[d]epending on the type of the defect, the operative site, and the esthetic requirements, each bone substitute can be used if properly adapted with a treatment plan.” They go on to suggest that “[f]urther studies, with a greater number and more homogenous group of samples, should be conducted to validate these findings and shed light to the concept of ridge preservation.”

A total of 32 participants, 19 men and 13 women aged 45 to 70 years needing tooth extraction, were enrolled in this randomized control, multiarm trial. Equal representation of the maxilla and mandible (n =16) was included. Each graft type was assessed through the following qualitative and quantitative variables: (i) graft particle present over time; (ii) structured bone density; (iii) osteoblastic and osteoclastic cell presence and activity level; and (iv) angiogenic activity around the bone regeneration site.

Zampara and colleagues observed that the alloplast group showed the highest vital bone percentage with the lowest residual graft particles. No significant differences in newly formed bone or percentage of residual graft particles were seen between the alloplast, allograft, or control groups. The xenograft presented the lowest amount of regenerated bone and the highest percentage of residual graft particles. All three graft materials resulted in effective alveolar ridge preservation as all surgeries were performed as planned, and none of the participants reported complications during the observed healing period.

The study results ultimately show that the allograft provides the greatest GBR potential for successful healing subsequent to necessary tooth extraction procedures. Zampara et al conclude that “[d]epending on the type of the defect, the operative site, and the esthetic requirements, each bone substitute can be used if properly adapted with a treatment plan.” They continue that “[f]urther studies, with a greater number and more homogenous group of samples, should be conducted to validate these findings and shed light to the concept of ridge preservation.”

Full text of the article, “A Histologic and Histomorphometric Evaluation of an Allograft, Xenograft, and Alloplast Graft for Alveolar Ridge Preservation in Humans: A Randomized Controlled Clinical Trial” Journal of Oral Implantology, Vol. 48, No. 6, 2022, is available at https://doi.org/10.1563/aaid-joi-D-21-00012

###

About the Journal of Oral Implantology

The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and of the American Academy of Implant Prosthodontics. It is dedicated to providing valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry. For more information about the journal or society, please visit http://www.joionline.org.

###

Media Contact:

Samantha Weinkauf

KnowledgeWorks Global Ltd

785/865-9123

Samantha.Weinkauf@kwglobal.com

Share article on social media or email:

Schenk poses with a colleague after being announced as the 2023 Child Life Specialist of the Year award recipient.

“Child life specialists play a critical role in supporting patients and families at Children’s Miracle Network Hospitals across the country.”

SALT LAKE CITY (PRWEB)
March 15, 2023

In honor of her dedication to change kids’ health for patients in Texas, Kaitlyn Lavery Schenk is being recognized by Children’s Miracle Network Hospitals and national corporate partner Ace Hardware with the 2023 Child Life Specialist of the Year award. This recognition is part of the celebration of Child Life Month in March.

Schenk got her start as a child life specialist in 2021. Her impact at The Children’s Hospital of San Antonio, a member hospital of Children’s Miracle Network Hospitals, reaches far and wide. She not only supports the patients and families treated in her unit but throughout the hospital, the city, and even throughout the state.

“Kaitlyn brings such light to the patients and families she serves at our hospital,” said Lyndsey Paulson, Director of Child Life and Volunteer Services, at The Children’s Hospital of San Antonio. “She is calm under stress and is able to meet families where they are in order to serve them best. I am thankful that she chooses to share her servant’s heart with all of us.”

In May 2022, when the tragic school shooting in Uvalde happened, Schenk was quick to support. Schenk and other Associates went to Uvalde Memorial Hospital and provided a safe space for their staff and children to express their feelings related to the trauma they had just experienced. Schenk prepared therapeutic activities for adults and children, put together educational resources for parents and caregivers on developmentally appropriate responses to trauma and death, and supported them in any other ways she could.

Schenk is frequently recognized by her peers for the compassionate care and creative legacy building she provides during end of life. She is passionate about serving patients with sensory needs or behavioral health concerns. Recently, she visited the local behavioral health facilities to learn about their admission processes in order to create preparation books that can be shared with families prior to discharge from the hospital. Schenk is working on creating a sensory-friendly room in the emergency department to best serve her patients.

Child life specialists like Schenk support the emotional and mental health needs of young, hospitalized patients and their families with programs that bring comfort, joy, and a sense of normalcy. These programs include art therapy, music therapy, pet therapy, play activities, and comfort toys and tools.

Funds raised by partners like Ace Hardware help support many areas of local member hospitals of Children’s Miracle Network Hospitals. Ace Hardware is known as the helpful place – retailers are hard-working, local, and loyal, just like child life specialists.

“The Ace team is incredibly proud of Kaitlyn and the amazing work she does to support children and families at The Children’s Hospital of San Antonio,” said Kane Calamari, President Ace Hardware Foundation. “Child life specialists play a critical role in supporting patients and families at Children’s Miracle Network Hospitals across the country. Congratulations, Kaitlyn!”

In celebration of Child Life Month, Ace Hardware with support from vendor Benjamin Moore, in partnership with Children’s Miracle Network Hospitals, is proud to be presenting the Child Life Specialist of the Year award to honor the hard work, compassion, and generous spirit of child life specialists like Schenk and to bring awareness to the need for child life funding at local member children’s hospitals. A $20,000 donation from the Ace Hardware Foundation will be given to The Children’s Hospital of San Antonio in Schenk’s name to be used unrestrictedly.

Philanthropy is essential to fund construction, innovative programs, and equipment purchases at The Children’s Hospital of San Antonio. Because of donations, physicians, nurses, and clinical teams continue to deliver the highest quality of medical care for pediatric patients. Donations restricted to Child Life help fund salaries, music therapy, the facility dog, supplies for medical play and distraction, holiday activities, and our Child Life Zone.

“Congratulations to the 2023 Child Life Specialist of the Year award recipient Kaitlyn Lavery Schenk,” said Teri Nestel, President & CEO of Children’s Miracle Network Hospitals. “We’re so grateful to partners like Ace Hardware who help make sure funding to local member hospitals can support child life departments and the invaluable care they provide to patients and families.”

Visit http://cmnhospitals.org to learn more about how Children’s Miracle Network Hospitals and its network supports the health of 10 million kids each year. Donations go to local hospitals to fund life-saving treatments, innovative research, vital medical equipment, child life services and financial assistance for kids and families. Together, we can change kids’ health. Together, we can change the future.

About Children’s Miracle Network Hospitals:

Children’s Miracle Network Hospitals® raises funds for 170 children’s hospitals that support the health of 10 million kids each year across the U.S. and Canada. Donations go to local hospitals to fund critical life-saving treatments and healthcare services, along with innovative research, vital pediatric medical equipment, child life services that put kids’ and families’ minds at ease during difficult hospital stays and financial assistance for families who could not otherwise afford these health services. When we improve the health of all children and allow them the opportunity to reach their full potential, we also improve our communities for years to come. Together, we can change kids’ health. Together, we can change the future. To learn about Children’s Miracle Network Hospitals and your local children’s hospital, visit http://cmnhospitals.org.

About Ace Hardware:

Ace Hardware is the largest retailer-owned hardware cooperative in the world with more than 5,600 locally owned and operated hardware stores in approximately 65 countries. Headquartered in Oak Brook, Ill, Ace and its subsidiaries operate an expansive network of distribution centers in the U.S. and have distribution capabilities in Ningbo, China; and Santa Catarina, Mexico. Since 1924, Ace has become a part of local communities around the world and know as the place with the helpful hardware folks. In 2022, Ace ranked “Highest in Customer Satisfaction with Home Improvement Retail Stores” according to J.D. Power, fifteen out of the last sixteen years. For more information, visit acehardware.com or newsroom.acehardware.com.

“This accreditation reinforces our long-term commitment to security and privacy, which helps reinforces our vision of breaking down all health data exchange barriers,” said Kevin Puscas, CTO of RosettaHealth.

WASHINGTON (PRWEB)
March 15, 2023

RosettaHealth, an innovative and secure, big health data interoperability platform, announced today it has achieved full accreditation with the DirectTrust Privacy & Security program from DirectTrust.

Direct Trusted Agent accreditation recognizes excellence in health data processing and transactions, and ensures compliance with industry-established standards, HIPAA regulations and the Direct Project. The DIRECTTRUST PRIVACY & SECURITY accreditation program accredits against HIPAA Privacy and Security requirements for organizations also pursuing DirectTrust accreditation as a Health Information Service Provider (HISP).

Through DirectTrust’s comprehensive third-party review, RosettaHealth was evaluated in areas of privacy, security and confidentiality; technical performance; business practices and organizational resources as it relates to Directed exchange participants. In addition, DirectTrust reviewed the organization’s process of managing and transferring protected health information and determined that the organization meets or exceeds all DirectTrust criteria and industry standards.

“The healthcare marketplace has an undeniable need for guidance and accountability on the secure and interoperable exchange of protected health information (PHI). Health Information Service Providers must carry out the responsibility for managing the intricate parts of the deployment of digital certificates for stakeholders to take advantage of Directed exchange of health information,” said Lee Barrett, Commission Executive Director, DirectTrust. “We congratulate RosettaHealth who has established and upheld a superior level of trust for their stakeholders by achieving the highest standards in privacy, security and confidentiality.”

RosettaHealth’s HealthBus solution is a SaaS-based data transport platform, which normalizes and transports health events and records (EHRs) at scale across a variety of organizations such as hospitals, HIEs, and urgent and acute care systems. The platform allows for health data exchange over wide geographic areas at a fraction of the cost and effort of traditional methods.

“This accreditation reinforces our long-term commitment to security and privacy, which helps reinforces our vision of breaking down all health data exchange barriers,” said Kevin Puscas, CTO of RosettaHealth. “We will continually focus on ensuring that the safe exchange of health data will lead to better care outcomes, and reduce overall costs.”

About RosettaHealth

The RosettaHealth platform is making electronic health record exchange affordable and ubiquitous. Currently, more than 40 million health records move across the platform per month. The SaaS platform enables efficiencies, scale and ease not seen before in records exchange. For more information about RosettaHealth, please click here.

About DirectTrust

DirectTrust™ is a non-profit, vendor-neutral alliance initially created by and for participants in the Direct community, including Health Information Service Providers (HISPs), Certificate Authorities (CAs), Registration Authorities (RAs), healthcare providers, consumers/patients, and Health IT vendors. DirectTrust serves as a governance forum, trust community, standards organization, and accreditation body for persons and entities engaged in exchange utilizing the Direct Standard™, supported by DirectTrust’s robust security and trust framework. The goal of DirectTrust is to develop, promote, and, as necessary, help enforce the rules and best practices necessary to maintain security and trust within the Direct Secure Messaging community. DirectTrust is committed to fostering widespread public confidence in the interoperable exchange of health information. To learn more, visit http://www.directtrust.org.

The DirectTrust Electronic Healthcare Network Accreditation Commission is a voluntary, standards development organization (SDO) established to develop standard criteria and accredit organizations that electronically exchange healthcare data. These entities include accountable care organizations, data registries, electronic health networks, EPCS vendors, e-prescribing solution providers, financial services firms, health information exchanges, health information service providers, management service organizations, medical billers, outsourced service providers, payers, practice management system vendors, third-party administrators and trusted networks. DirectTrust is an authorized HITRUST External Assessor, making it the only organization able to provide both DirectTrust Electronic Healthcare Network Accreditation Commission accreditation as well as to conduct HITRUST CSF assessment services.

Guided by peer evaluation, the DirectTrust accreditation process promotes quality service, innovation, cooperation and open competition in healthcare. To learn more, visit http://www.DirectTrust.org, contact Admin@DirectTrust.org, or follow us on Twitter, LinkedIn and Y ouTube.

###

Share article on social media or email:

We are proud to bring this new medical office building to life on behalf of Children’s Wisconsin to support their goal of bringing specialized pediatric care closer to families.

MILWAUKEE (PRWEB)
March 15, 2023

Hammes, a nationally recognized leader in healthcare development, is pleased to celebrate the opening of the new Children’s Wisconsin Appleton Clinic in Appleton, Wisconsin, which opened to patients on March 6.

The new two-story, 54,000-square-foot location allows Children’s Wisconsin to expand existing pediatric services and provide new specialties to families in Northeast and Central Wisconsin. The clinic will offer more than 20 specialty care services, including asthma/allergy, audiology, cardiology, imaging, lab, physical and occupational therapy, and speech therapy.

“We are proud to bring this new medical office building to life on behalf of Children’s Wisconsin to support their goal of bringing specialized pediatric care closer to families,” said Todd Kibler, Managing Principal of Hammes Partners.

Hammes will retain ownership of the new clinic and provide property management services, as it does for the Children’s Wisconsin Kenosha Clinic in Kenosha, Wisconsin.

About Hammes

Founded in 1991, Hammes is a vertically integrated real estate solutions platform specializing in healthcare real estate strategy and planning, project management, development, investment, and property management. As a testament to our deep healthcare industry experience, Hammes has been recognized as one of the nation’s leading healthcare developers by Modern Healthcare’s Construction & Design Survey for 24 consecutive years—including 19 years as No. 1— and by Revista’s Outpatient Healthcare Real Estate Development Report. Headquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States. http://www.hammes.com

Share article on social media or email: